07:41 AM EST, 12/09/2024 (MT Newswires) -- BioAge Labs ( BIOA ) shares slumped 70% pre-bell Monday after the company said late Friday it is terminating a phase 2 trial of its obesity drug candidate following observations of liver transaminitis.

Universe Pharmaceuticals ( UPC ) shares fell 54% after the company unveiled a $15 million registered direct offering of ordinary shares and warrants.

Radiopharm Theranostics ( RADX ) shares dropped 25% after Friday's 7% increase.

Palmer Square Capital (PSBD) shares retreated 18% following a 1.3% gain in the previous session.

Forrester Research ( FORR ) shares were down 17% following a muted session.